PFA
FFTY icon

Pathway Financial Advisers’s CapForce IBD 50 ETF FFTY Stock Holding History

Pathway Financial Advisers’s Portfolio FFTY Stock Details FFTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-89
Closed -$2.45K – 427
2024
Q2 		$2.45K Sell
89
-104
-54% -$2.83K ﹤0.01% 420
2024
Q1 		$5.34K Sell
193
-67
-26% -$1.75K ﹤0.01% 391
2023
Q4 		$6.32K Hold
260
– – ﹤0.01% 394
2023
Q3 		$5.81K Buy
+260
New +$6.28K ﹤0.01% 407
2023
Q1 		$6.13K Sell
260
-93
-26% -$2.14K ﹤0.01% 426
2022
Q4 		$7.71K Buy
+353
New +$8.71K ﹤0.01% 455

Other funds holding FFTY

IPW
IronBridge Private Wealth Austin, Texas $310M AUM 41.13% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CL
COWA LLC Tulsa, Oklahoma $371M AUM 22.68% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Pathway Financial Advisers's FFTY Position: Q3 2024 in Review

Pathway Financial Advisers sold out of CapForce IBD 50 ETF (FFTY) in Q3 2024, closing a stake of 89 shares — an estimated $2.45K sold.

Pathway Financial Advisers first reported a position in FFTY in Q4 2022 and held it in 6 quarters. The position peaked at $7.71K in Q4 2022. 29 funds tracked by Wall St. Rank hold FFTY as of Q3 2024.

  • Pathway Financial Advisers reported no remaining CapForce IBD 50 ETF position as of Q3 2024 after selling out during the quarter.
  • Pathway Financial Advisers sold 89 CapForce IBD 50 ETF shares in Q3 2024, an estimated $2.45K.
  • Pathway Financial Advisers first reported a position in CapForce IBD 50 ETF in Q4 2022 and held it in 6 quarters.
  • Pathway Financial Advisers's CapForce IBD 50 ETF position peaked at $7.71K in Q4 2022.
  • 29 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2024.

Based on Pathway Financial Advisers's 13F filing for Q3 2024, filed 24 Oct 2024.